Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TFF Pharmaceuticals Inc TFFP

Healthcare
TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaging patented rapid freezing technology to develop and transform medicine into potent dry powder. It is focused on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform. Its TFF technology platform has an applicability to convert any drug, including vaccines... see more

Recent & Breaking News (NDAQ:TFFP)

TFF Pharmaceuticals to Hold Third Quarter 2022 Financial and Business Results Conference Call on November 14, 2022

GlobeNewswire November 7, 2022

TFF Pharmaceuticals Announces Collaboration with Aptar Pharma to Explore and Develop Intranasal Delivery of Dry Powder Vaccines and Dry Powder Therapeutics

GlobeNewswire November 3, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TFF Pharmaceuticals, Inc. - TFFP

Newsfile November 1, 2022

TFF Pharmaceuticals Announces Second Patient Successfully Treated with Voriconazole Inhalation Powder Through Compassionate Use Program

GlobeNewswire November 1, 2022

TFF Pharmaceuticals Announces Program Updates for Voriconazole Inhaled Powder and Tacrolimus Inhaled Powder Clinical Programs

GlobeNewswire November 1, 2022

TFF Pharmaceuticals Announces Presentation of Data Featuring Applications of Thin Film Freezing Technology at AAPS PharmSci 360 Meeting

GlobeNewswire October 11, 2022

TFF Pharmaceuticals to Participate in the Roth Inaugural Healthcare Opportunities Conference

GlobeNewswire September 26, 2022

TFF Pharmaceuticals Announces Acceptance of Multiple Abstracts Featuring Applications of Thin Film Freezing Technology at the Upcoming AAPS PharmSci 360 Meeting

GlobeNewswire September 22, 2022

TFF Pharmaceuticals Announces Presentation of Patient Data with Voriconazole Inhalation Powder (TFF VORI) at the 15th International Congress on Lung Transplantation

GlobeNewswire September 8, 2022

TFF Pharmaceuticals to Participate at The H.C. Wainwright 24th Annual Global Investment Conference

GlobeNewswire September 6, 2022

TFF Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

GlobeNewswire August 11, 2022

TFF Pharmaceuticals to Hold Second Quarter 2022 Financial and Business Results Conference Call on August 11, 2022

GlobeNewswire August 2, 2022

TFF Pharmaceuticals Expands R&D Operations with New Austin Facility

GlobeNewswire July 14, 2022

TFF Pharmaceuticals to Participate at The JMP Securities Life Sciences Conference

GlobeNewswire June 9, 2022

TFF Pharmaceuticals to Participate at the Jefferies Healthcare Conference

GlobeNewswire June 1, 2022

TFF Pharmaceuticals to Participate at the H.C. Wainwright Global Investment Conference

GlobeNewswire May 20, 2022

TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

GlobeNewswire May 11, 2022

TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)

GlobeNewswire May 2, 2022

TFF Pharmaceuticals to Hold First Quarter 2022 Financial and Business Results Conference Call on May 11, 2022

GlobeNewswire April 29, 2022

TFF Pharmaceuticals Announces Safety and Pharmacokinetic Data from Phase 1 Study of Niclosamide Inhalation Powder

GlobeNewswire April 19, 2022